Stocks · US
TEVA
XNYS
Teva Pharmaceutical Industries Limited
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E65.42x
P/B5.97x
P/S2.67x
EPS$0.61
ROE9.12%
ROA1.77%
Dividend yield0.00%
EV/EBITDA13.94x
Debt/Equity2.14
Free cash flow$1.3B
Returns and 52-week range
1W-1.71%
1M+7.62%
3M+17.72%
6M+33.41%
1Y+95.55%
YTD+26.43%
52W high$40.79
52W low$18.82
From 52W high-4.07%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Agilent Technologies Inc. | $48.3B | 33.54 | 6.56 | +12.24% |
| Veeva Systems Inc. | $45.9B | 45.22 | 6.18 | +3.06% |
| 휴마나 | $48.5B | 37.94 | 2.53 | +0.68% |
| Illumina Inc | $44.3B | 53.75 | 15.63 | +25.35% |
| Becton, Dickinson and Co. | $49.2B | 52.30 | 2.02 | -2.40% |
| 아이큐비아 홀딩스 | $43.8B | 31.85 | 7.10 | -2.91% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.